Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Gastric Cancer
- Gastrostomy
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Gastric cancer patients with clinical stage T1/2 will be screened for the study. For the patients enrolled, a multidisciplinary discussion will be performed to evaluate the proper gastrectomy for the patients and functional preserving gastrectomy will be considered for the indicated patients. For pa...
Gastric cancer patients with clinical stage T1/2 will be screened for the study. For the patients enrolled, a multidisciplinary discussion will be performed to evaluate the proper gastrectomy for the patients and functional preserving gastrectomy will be considered for the indicated patients. For patients not proper for functional preserving gastrectomy, standard gastrectomies will be suggested. After surgery, a close follow up will be performed. During the study, a thorough data collection will be performed to evaluate the safety and effectiveness of functional preserving gastrectomy and recovery and postoperative function of remnant stomach.
Tracking Information
- NCT #
- NCT03874871
- Collaborators
- Beijing Municipal Science & Technology Commission
- Peking Union Medical College Hospital
- Beijing Friendship Hospital
- Peking University Third Hospital
- Chinese PLA General Hospital
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Beijing Hospital
- Peking University People's Hospital
- Investigators
- Study Chair: Ziyu Li, MD Beijing Cancer Hospital